NCT01149746

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

A Single-Dose, Comparative Bioavailability Study of Two Formulations of Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Teva Pharmaceuticals USA · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to evaluate the comparative bioavailability between Tamsulosin Hydrochloride 0.4 mg Capsules (Teva Pharmaceuticals USA) and Flomax® 0.4 mg Capsules (Boehringer Ingelheim Pharmaceuticals, Inc. USA), after a single-dose in healthy subjects under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Tamsulosin	Test 0.4 mg Capsule
DRUG	Tamsulosin	Reference Listed 0.4 mg Capsule

Timeline

• Start date: 2004-12-01
• Primary completion: 2004-12-01
• Completion: 2004-12-01
• First posted: 2010-06-23
• Last updated: 2010-06-23

Locations

1 site across 1 country: Canada